Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.61 USD | -3.50% | -15.28% | -87.56% |
Mar. 15 | Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating | MT |
Mar. 14 | Quoin Pharmaceuticals Seeks M&A Opportunities | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.56% | 2.33M | |
+1.40% | 43.84B | |
+5.66% | 41.68B | |
+44.81% | 41.25B | |
-10.92% | 27.04B | |
+7.66% | 25.53B | |
-25.33% | 18.18B | |
-2.34% | 12.29B | |
+24.64% | 12.29B | |
+6.96% | 11.15B |
- Stock Market
- Equities
- QNRX Stock
- News Quoin Pharmaceuticals, Ltd.
- Cellect Biotechnology : Shareholders OK Merger With Quoin Pharmaceuticals, Sale of Cellect Biotherapeutics Subsidiary